Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER
Shaman AM, Bain SC, Bakris GL, et al.
Circulation. 2022;145(8):575-585.
Leggi


